Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-10-25

FDA Approved: PROCHLORPERAZINE EDISYLATE — Original Application (Mylan Institutional LLC)

View source ↗

Summary

The FDA approved the original ANDA for Prochlorperazine Edisylate by Mylan Institutional LLC, enabling a generic version of this antiemetic. This marks the mark…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Prochlorperazine edisylate (Prochlorperazine edisylate)

Snippet

ORIG AP for PROCHLORPERAZINE EDISYLATE (PROCHLORPERAZINE EDISYLATE)